Matthew Gline
CIK 1750094 · CEO · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$502.75M
Companies
2
Total Filings
55
Lifetime Open-Market Net
-$71.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | CEO | 16,736,116 | $30.04 | $502.75M | -$69.51M | 29 | 2026-04-20 |
| Roivant Sciences Ltd. (ROIVW) Delisted | CEO | 1,051,732 | $2.75 | $2.89M | -$2.22M | 26 | 2023-08-29 |
Recent Filings · Page 6 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-22 | Roivant Sciences Ltd. (ROIVW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-01 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | −58,940 | -$282.7K | EDGAR |
| 2022-03-29 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −35,386 | -$179.1K | EDGAR |
| 2022-03-22 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −82,006 | -$420.7K | EDGAR |
| 2022-03-09 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −92,324 | -$509.6K | EDGAR |
Showing 51–55 of 55
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.